Response to the Letter to the Editor: "Reaffirming Caution-The Unacceptable Vasoconstrictive Risk of CGRP-Related Therapies in Moyamoya Angiopathy"
Eur J Neurol
.
2026 Jan;33(1):e70470.
doi: 10.1111/ene.70470.
Authors
Nicola Rifino
1
,
Anne Hege Aamodt
2
,
Markus Wiedmann
3
,
Markus Kramer
4
,
Jana Becker
4
,
Stéphanie Guey
5
,
Francesco Acerbi
6
,
Dominique Herve
5
,
Anna Bersano
1
Affiliations
1
Cerebrovascular Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
2
Department of Neurology, Oslo University Hospital, Oslo, Norway.
3
Department of Neurosurgery, Oslo University Hospital, Oslo, Norway.
4
Department of Neurology, Alfried Krupp Hospital, Essen, Germany.
5
CNVT-CERVCO et département de Neurologie, Hôpital Lariboisière, APHP Nord, Paris, France.
6
Department of Neurosurgery, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
PMID:
41508730
PMCID:
PMC12783910
DOI:
10.1111/ene.70470
No abstract available
Publication types
Letter